Last $5.79 USD
Change Today -0.01 / -0.17%
Volume 12.4K
CBRX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

columbia laboratories inc (CBRX) Snapshot

Open
$5.82
Previous Close
$5.80
Day High
$5.85
Day Low
$5.74
52 Week High
03/18/14 - $7.50
52 Week Low
10/14/14 - $5.30
Market Cap
62.4M
Average Volume 10 Days
18.9K
EPS TTM
$-0.15
Shares Outstanding
10.8M
EX-Date
--
P/E TM
--
Dividend
$1.00
Dividend Yield
--
Current Stock Chart for COLUMBIA LABORATORIES INC (CBRX)

Related News

No related news articles were found.

columbia laboratories inc (CBRX) Related Businessweek News

No Related Businessweek News Found

columbia laboratories inc (CBRX) Details

Columbia Laboratories, Inc. provides pharmaceutical development, clinical trial manufacturing, and analytical and consulting services to the pharmaceutical industry. It focuses on the sale of CRINONE, a progesterone gel to its marketing partner. The company has licensed CRINONE to Merck Serono S.A. outside the United States; and has sold the rights to CRINONE to Actavis, Inc. in the United States. Columbia Laboratories, Inc. was founded in 1986 and is headquartered in Boston, Massachusetts.

77 Employees
Last Reported Date: 03/5/14
Founded in 1986

columbia laboratories inc (CBRX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $340.0K
Director and Chief Executive Officer of Molec...
Total Annual Compensation: $86.0K
Advisor
Total Annual Compensation: $271.1K
Compensation as of Fiscal Year 2013.

columbia laboratories inc (CBRX) Key Developments

Columbia Laboratories Inc., Board Meeting, Sep 12, 2014

Columbia Laboratories Inc., Board Meeting, Sep 12, 2014. Agenda: To consider the employment agreement with Mr. George O. Elston.

Columbia Laboratories Inc. Announces Management Changes

Columbia Laboratories Inc. announced that the Board has named George O. Elston, as Chief Financial Officer, effective October 1, 2014. He succeeds Jonathan Lloyd Jones, who is stepping down from the role to pursue other opportunities. Mr. Elston joins Columbia from KBI Biopharma where he served as Senior Vice President and CFO, and was responsible for all financial operations.

Columbia Laboratories Announces Completion of CRINONE License Renewal

Columbia Laboratories Inc. announced that Merck Serono has completed a routine license renewal for CRINONE in one of its biggest markets. Normalized shipments are expected to resume at the beginning of 2015. The new license will be in place for five years.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CBRX:US $5.79 USD -0.01

CBRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $41.46 USD +0.60
View Industry Companies
 

Industry Analysis

CBRX

Industry Average

Valuation CBRX Industry Range
Price/Earnings 19.9x
Price/Sales 2.2x
Price/Book 1.6x
Price/Cash Flow 18.2x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COLUMBIA LABORATORIES INC, please visit www.columbialabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.